[1]
“Molecular docking investigation of the amantadine binding to the enzymes upregulated or downregulated in Parkinson’s disease”, ADMET DMPK, vol. 8, no. 2, pp. 149–175, Jun. 2020, doi: 10.5599/admet.854.